tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Casi Pharmaceuticals appoints Barbara Krebs-Pohl to board of directors
PremiumThe FlyCasi Pharmaceuticals appoints Barbara Krebs-Pohl to board of directors
1M ago
CASI Pharmaceuticals Reports Q2 2025 Results and Strategic Asset Divestiture
Premium
Company Announcements
CASI Pharmaceuticals Reports Q2 2025 Results and Strategic Asset Divestiture
1M ago
CASI Pharmaceuticals Faces Setback with FOLOTYN® License Expiration in China
Premium
Company Announcements
CASI Pharmaceuticals Faces Setback with FOLOTYN® License Expiration in China
1M ago
Casi Pharmaceuticals to hold a conference call
PremiumThe FlyCasi Pharmaceuticals to hold a conference call
5M ago
CASI Pharmaceuticals Schedules Business Update Amid Legal Proceedings
Premium
Company Announcements
CASI Pharmaceuticals Schedules Business Update Amid Legal Proceedings
5M ago
CASI Pharmaceuticals: Strategic Divestments and Promising Clinical Developments Drive Buy Rating
Premium
Ratings
CASI Pharmaceuticals: Strategic Divestments and Promising Clinical Developments Drive Buy Rating
5M ago
CASI Pharmaceuticals Divests Chinese Assets in $20 Million Deal
PremiumCompany AnnouncementsCASI Pharmaceuticals Divests Chinese Assets in $20 Million Deal
5M ago
CASI Pharmaceuticals Faces Nasdaq Compliance Challenge
Premium
Company Announcements
CASI Pharmaceuticals Faces Nasdaq Compliance Challenge
5M ago
Casi Pharmaceuticals receives Nasdaq deficiency notice
Premium
The Fly
Casi Pharmaceuticals receives Nasdaq deficiency notice
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100